USFDA Issues 22 Observations to Lupin’s Site in Mandideep, India
Resilinc-blog

According to Business Standard, US FDA has issued 22 observations for Lupin after inspection of its facilities located at Mandideep in Madhya Pradesh, India as reported on Thursday, December 6.

Read All Global Disruptions

Recent Global Disruptions